Gene therapy has been hindered by the low frequency of homologous recombination in mammalian cells. To stimulate recombination, we investigated the use of triple-helix-forming oligonucleotides (TFOs) to target DNA damage to a selected site within cells. By treating cells with TFOs linked to psoralen, recombination was induced within a simian virus 40 vector carrying two mutant copies of the supF tRNA reporter gene. Gene conversion events, as well as mutations at the target site, were also observed. The variety of products suggests that multiple cellular pathways can act on the targeted damage, and data showing that the triple helix can influence these pathways are presented. The ability to specifically induce recombination or gene conversion within mammalian cells by using TFOs may provide a new research tool and may eventually lead to novel applications in gene therapy.Gene targeting has been used to introduce foreign DNA into the genomes of mammalian cells through site-specific homologous recombination. By targeting specific genes in embryonic stem cells, it is now possible to study the role of individual genes in laboratory animals (27). However, the frequency of targeted recombination in mammalian cells is low, and the ratio of homologous to nonhomologous integration events is often unfavorable (15,44). This low frequency of homologous recombination limits the use of this technology for the purpose of gene therapy, and therefore efforts have been made to improve the efficiency of gene targeting.Previous studies have indicated that a double-strand break (DSB) within the region of homology in the donor molecule can enhance the recombination and targeting frequency (16,22). However, this increase is modest, and the DSB is likely to result in an increase in nonhomologous recombination as well. Recently, efforts have also been directed toward modification of the recipient site to create a substrate prone to homologous recombination. It has been shown that a site-specific endonuclease, I-SceI, can induce DSBs within extrachromosomal and genomic DNA designed to carry the rare 18-bp recognition site. This strategy has been used to induce intermolecular recombination in both Xenopus oocytes (40) and mammalian cells (5, 37). However, this strategy has limited practical application, as it involves the prior introduction of the recognition site within the genome.Besides DSBs, other types of DNA damage have been shown to be recombinogenic. These include DNA damage from UV radiation (45), chemical carcinogens (52), and photoreactive molecules such as psoralen (38). Psoralens are DNA-damaging agents that intercalate into DNA and form covalent monoadducts (MAs) and interstrand cross-links (XLs) upon exposure to near-UV light (UVA). Photo-induced psoralen interstrand XLs, and to a lesser extent MAs, can induce recombination in bacterial (7, 25), yeast (38), and mammalian (48) cells.In these studies of psoralen-induced recombination, however, there was no specificity to the distribution of psoralen adducts other than that der...